Filing Flows › Cardio Diagnostics Holdings (CDIO) › Q3 2026
Cardio Diagnostics Holdings (CDIO) Q3 2026 earnings results (third quarter 2026)
10-Q filed Nov 6, 2026
Cardio Diagnostics Holdings (CDIO) reported revenue of $4K for the third quarter 2026 (Q3 2026), +26% from a year earlier and -33% from the quarter before.
Cardio Diagnostics Holdings, Q3 2026: revenue $4K (+26% year over year), net loss $1.7M, operating cash flow −$1.5M. The chart follows the revenue to costs, profit and cash.
| Q3 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $4K | -33% | +26% |
| Operating profit | −$1.7M | — | — |
| Net earnings | −$1.7M | — | — |
| Operating cash flow | −$1.5M | — | — |
What changed
Revenue was $4K in Q3 2026, up 26% year over year and down 33% from the previous quarter.
Operating costs exceeded revenue by $1.7M, an operating margin of -48193.8%. Total costs grew 1% against revenue growth of 26%. The quarter ended with a net loss of $1.7M, wider than the previous quarter's $1.5M loss.
Operating cash flow was −$1.5M. Non-cash charges added back $6K of depreciation and amortization and $24K of share-based compensation. Working capital and other items added $186K.
Questions
What was Cardio Diagnostics Holdings' revenue in the third quarter 2026?
Cardio Diagnostics Holdings (CDIO) reported revenue of $4K for the third quarter 2026 (Q3 2026), +26% from a year earlier and -33% from the quarter before.